CVRx, Inc.
CVRX Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$1.45
KIRA · Stoqly’s AI analyst, in plain words
- CVRx, Inc. had $56.7M of revenue in fiscal 2025, up 10.4% on the year before. Over five years, revenue changed +56.4% a year on average.
- Its operating margin was −90.5%, up 25.5 pts: of every 100 in sales, about −90 is left after running the business.
- CVRx, Inc. lost $53.3M in fiscal 2025.
- Free cash flow was −$40.8M in fiscal 2025, −71.9% of revenue.
- CVRx, Inc. has $26.2M more cash than debt.
Market cap
$38.4M
P/E
—
Revenue
$56.7M
Net income
−$53.3M
Free cash flow
−$40.8M
Operating margin
−90.5%
CVRx, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+10.4%
Yes. Sales grew 10.4% last year.
Does it make a profit?
−94.1%
No. It lost money last year.
Does profit turn into cash?
−71.9%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What CVRx, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 13, 2026
- Legal name
- CVRx, Inc.
- CIK
- 0001235912
CVRx, Inc. · CVRX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $13.0M | $22.5M | $39.3M | $51.3M | $56.7M |
| Revenue growth | 115.4% | 72.4% | 74.9% | 30.5% | 10.4% |
| Gross margin | 72.1% | 77.8% | 84.1% | 83.8% | 85.3% |
| Operating margin | −199.2% | −189.3% | −109.7% | −116.0% | −90.5% |
| Net income | −$43.1M | −$41.4M | −$41.2M | −$60.0M | −$53.3M |
| Net margin | −330.5% | −184.4% | −104.8% | −116.9% | −94.1% |
| Diluted EPS | −$4.16 | −$2.02 | −$1.99 | −$2.65 | −$2.04 |
| Cash | |||||
| Cash from operations | −$27.7M | −$42.7M | −$39.0M | −$39.1M | −$40.2M |
| Capital expenditure | $1.2M | $0.7M | $0.6M | $1.4M | $0.6M |
| Free cash flow | −$28.9M | −$43.4M | −$39.6M | −$40.5M | −$40.8M |
| FCF margin | −221.8% | −193.0% | −100.8% | −79.0% | −71.9% |
| Share count change | 2,576.3% | 98.2% | 1.1% | 8.9% | 15.4% |
| Debt and strength | |||||
| Cash and short-term investments | $142M | $106M | $90.6M | $106M | $75.7M |
| Debt incl. finance leases | $0.0M | $6.7M | $29.2M | $49.3M | $49.5M |
| Shareholders' equity | $146M | $109M | $75.9M | $71.1M | $39.3M |
| Current ratio | 25.6x | 15.2x | 14.3x | 12.1x | 7.6x |
| Interest coverage | −11.7x | −257.7x | −24.0x | −13.5x | −8.8x |
| Returns and quality | |||||
| Return on capital | −527.8% | −345.2% | −233.2% | −326.5% | −308.4% |
| Return on equity | — | −32.5% | −44.5% | −81.6% | −96.6% |
| Return on tangible equity | −29.5% | −37.9% | −54.2% | −84.4% | −135.6% |
| Piotroski F-score | 3 | 2 | 3 | 2 | 3 |
| Altman Z'' | 19.9 | −0.4 | −8.1 | −9.1 | −15.5 |
Insiders bought, 12 months
$0.4M
2 insiders
Insiders sold, 12 months
$0.8M
8 insiders
Of sales under plans
17%
$0.1M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
CVRx, Inc. · CVRX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.45 a share, the company is worth $38.4M.
Source: SEC EDGAR XBRL filings (CIK 0001235912). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.